Does antenatal micronutrient supplementation improve children's cognitive function? Evidence from the follow-up of a
Sophiya Dulal1, Frédérique Liégeois2, David Osrin3
1Mother and Infant Research Activities (MIRA), Kathmandu, Nepal.
Insights
Antenatal multiple micronutrient (MMN) supplementation did not improve children's intelligence or executive function by age 12 compared to iron and folic acid (IFA) only. This study followed children in Nepal from a randomized controlled trial.
Area of Science:
- Maternal and child health
- Nutritional science
- Cognitive development
Background:
- Multiple micronutrient (MMN) supplementation during pregnancy is linked to improved infant outcomes and potential cognitive benefits.
- Undernutrition in pregnancy is common in many regions, highlighting the importance of adequate nutrient intake for fetal development.
- Previous research suggests MMN may enhance cognitive function through improved fetal brain development and birth weight.
Purpose of the Study:
- To test the hypothesis that children whose mothers received MMN supplementation during pregnancy would exhibit higher intelligence in early adolescence compared to those receiving only Iron and Folic Acid (IFA).
- To evaluate the long-term effects of antenatal MMN supplementation on cognitive abilities, specifically intelligence and executive function, in children at 12 years of age.
Main Methods:
- Follow-up of children from a double-blind Randomized Controlled Trial (RCT) conducted in Nepal.
- Assessment of children's Full Scale Intelligence Quotient (FSIQ) using the Universal Non-verbal Intelligence Test (UNIT).
- Evaluation of executive function using the counting Stroop test.
Main Results:
- No significant differences in Full Scale Intelligence Quotient (FSIQ) at 12 years were observed between the MMN and IFA groups.
- No differences were found in specific cognitive domains including memory, reasoning, and symbolic/non-symbolic quotients as assessed by the UNIT.
- The study identified 813 children (76%) for follow-up from the original 1069 participants.
Conclusions:
- Antenatal multiple micronutrient (MMN) supplementation showed no demonstrable benefit for children's overall intelligence or executive function at 12 years of age when compared to Iron and Folic Acid (IFA) supplementation.
- The findings suggest that MMN supplementation during pregnancy may not confer lasting advantages in cognitive development up to early adolescence in this population.
- Further research may be needed to explore potential benefits in different populations or at different developmental stages.
Introduction:
Multiple Micronutrient (MMN) supplementation during pregnancy can decrease the proportion of infants born low birth weight and small for gestational age. Supplementation could also enhance children's cognitive function by improving access to key nutrients during fetal brain development and increasing birth weight, especially in areas where undernutrition is common. We tested the hypothesis that children whose mothers received MMN supplementation during pregnancy would have higher intelligence in early adolescence compared with those receiving Iron and Folic Acid (IFA) only.
Methods:
We followed up children in Nepal, whose mothers took part in a double-blind Randomised Controlled Trial (RCT) that compared the effects on birth weight and gestational duration of antenatal MMN versus IFA supplementation. We assessed children's Full Scale Intelligence Quotient (FSIQ) using the Universal Non-verbal Intelligence Test (UNIT), and their executive function using the counting Stroop test. The parent trial was registered as ISRCTN88625934.
Results:
We identified 813 (76%) of the 1069 children whose mothers took part in the parent trial. We found no differences in FSIQ at 12 years between MMN and IFA groups (absolute difference in means (diff): 1.25, 95% CI -0.57 to 3.06). Similarly, there were no differences in mean UNIT memory (diff: 1.41, 95% CI -0.48 to 3.30), reasoning (diff: 1.17, 95% CI -0.72 to 3.06), symbolic (diff: 0.97, 95% CI -0.67 to 2.60) or non-symbolic quotients (diff: 1.39, 95% CI -0.60 to 3.38).
Conclusion:
Our follow-up of a double-blind RCT in Nepal found no evidence of benefit from antenatal MMN compared with IFA for children's overall intelligence and executive function at 12 years.
More Related Videos
05:44Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1
Published on: May 17, 2024
03:19Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes
Published on: June 28, 2024
Related Concept Videos
Environmental Influences on Intelligence
The Nativist Approach
Information Processing Approach
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
